TIA (Transient Ischemic Attack)
11
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
27%
3 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (11)
Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation
Testing the Effectiveness of a Novel Intervention to Improve Medication Adherence in Stroke Survivors
Prospective Registry of Vertigo Due to Vertebrobasilar Transient Attacks.
Transient Ischemic Attack (TIA) and Spoken Language
Cilostazol for Prevention of Recurrent Stroke Trial
Integrated Approach in Frail Older People with Atrial Fibrillation
Evaluation of the Efficacy of Novel Biomarkers in Predicting Clopidogrel Resistance in Patients with Ischemic Stroke
Cardiac Rehabilitation for TIA Patients
Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034)
Sms-guided Training After Acute Stroke or Transient Ischemic Attack - a Randomized Controlled Trial
Mechanistic Study of Bleeding Risk in Coronary Patients With Cerebrovascular Disease